Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification

作者: Karina Drumm , Stefan Hubert Schlör , Frank Göhring

DOI:

关键词:

摘要: Provided are methods for the treatment of disorders central nervous system (CNS) and eye. In particular, use compositions comprising a compound capable modulating target gene or product is described preparation pharmaceutical composition CNS and/or eye, wherein designed to be administered outside blood-CNS blood-retina barriers. Furthermore, provided identifying obtaining nucleic acid molecules encoding polypeptides involved in diagnosing said as well transgenic animal deficient expression genes identified accordance with method. addition, isolating drugs that particularly useful related eye disclosed.

参考文章(254)
Mark J. Walport, Complement. Second of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1140- 1144 ,(2001) , 10.1056/NEJM200104123441506
M. Heideman, A. Bengtsson, The Role of Complement Springer Berlin Heidelberg. pp. 25- 35 ,(1993) , 10.1007/978-3-642-76736-4_3
Arinobu Tojo, Sachiko Yamaguchi, Masabumi Shibuya, Hitoshi Matsushime, Misako Sato, Toshio Ikeda, Akira Yamane, Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. ,vol. 5, pp. 519- 524 ,(1990)
Mark J. Walport, Complement. First of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1058- 1066 ,(2001) , 10.1056/NEJM200104053441406
Ian Constable, Chooi-May Lai, Piroska Elizabeth Rakoczy, Wei-Yong Shen, The use of adenovirus-mediated gene transfer to develop a rat model for photoreceptor degeneration. Investigative Ophthalmology & Visual Science. ,vol. 41, pp. 580- 584 ,(2000)
Glen R. Nemerow, Marty Friedlander, Seggern Daniel J. Von, Vectors for ocular transduction and use thereof for genetic therapy ,(2001)
Nan Sook Lee, Taikoh Dohjima, Gerhard Bauer, Haitang Li, Ming-Jie Li, Ali Ehsani, Paul Salvaterra, John Rossi, Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells Nature Biotechnology. ,vol. 20, pp. 500- 505 ,(2002) , 10.1038/NBT0502-500
Stanley T. Crooke, Progress in antisense technology: the end of the beginning. Methods in Enzymology. ,vol. 313, pp. 3- 45 ,(2000) , 10.1016/S0076-6879(00)13003-4